Used primarily in pharmaceutical research, this compound is investigated for its potential as a central nervous system (CNS) agent. It is studied for its interaction with neurotransmitter receptors, particularly serotonin and dopamine receptors, which are critical in treating psychiatric and neurological disorders such as depression, anxiety, and schizophrenia. Additionally, its structural features make it a candidate for developing drugs targeting neurodegenerative diseases. Researchers also explore its potential in pain management and as an anti-inflammatory agent due to its modulatory effects on specific biochemical pathways.